MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 99 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $6,852,712 | +137.7% | 24,460 | +96.3% | 0.04% | +131.6% |
Q4 2023 | $2,882,532 | -72.4% | 12,458 | -82.6% | 0.02% | -76.5% |
Q3 2023 | $10,446,971 | +127.7% | 71,535 | +260.1% | 0.08% | +107.7% |
Q2 2023 | $4,588,815 | -38.5% | 19,865 | -77.9% | 0.04% | -45.1% |
Q1 2023 | $7,457,332 | +44.9% | 89,804 | +39.0% | 0.07% | +65.1% |
Q4 2022 | $5,145,150 | -2.5% | 64,600 | -60.6% | 0.04% | -2.3% |
Q3 2022 | $5,277,000 | +496.9% | 164,036 | +1228.5% | 0.04% | +388.9% |
Q2 2022 | $884,000 | +17.2% | 12,347 | +38.7% | 0.01% | +28.6% |
Q4 2021 | $754,000 | +62.9% | 8,905 | +53.5% | 0.01% | +40.0% |
Q3 2021 | $463,000 | -23.3% | 5,800 | -6.5% | 0.01% | -16.7% |
Q2 2021 | $604,000 | -83.0% | 6,200 | -79.6% | 0.01% | -86.0% |
Q1 2021 | $3,562,000 | +360.8% | 30,454 | +368.0% | 0.04% | +186.7% |
Q3 2020 | $773,000 | -56.7% | 6,507 | -58.7% | 0.02% | -37.5% |
Q2 2020 | $1,786,000 | +237.6% | 15,770 | +99.1% | 0.02% | -27.3% |
Q1 2020 | $529,000 | +56.5% | 7,921 | +193.4% | 0.03% | +175.0% |
Q1 2019 | $338,000 | -90.3% | 2,700 | -91.3% | 0.01% | -91.0% |
Q4 2018 | $3,483,000 | -72.8% | 30,900 | -48.4% | 0.13% | -76.5% |
Q3 2018 | $12,827,000 | +677.4% | 59,900 | +915.3% | 0.57% | +540.4% |
Q2 2018 | $1,650,000 | +272.5% | 5,900 | +55.6% | 0.09% | +169.7% |
Q1 2018 | $443,000 | – | 3,792 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |